杏林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4569/E00985 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/11/13 | 日証協 | 519,946株 | -6.21% | 16,100株 | -88.76% | 579,378株 | -3.94% | 53,336株 | +67.36% |
2015/11/06 | 日証協 | 554,346株 | -2% | 143,224株 | +916.57% | 603,170株 | -5.49% | 31,869株 | +4.75% |
2015/10/30 | 日証協 | 565,646株 | -1.65% | 14,089株 | +42.86% | 638,190株 | -1.22% | 30,425株 | +607.39% |
2015/10/23 | 日証協 | 575,157株 | +0.07% | 9,862株 | 0% | 646,075株 | -3.98% | 4,301株 | -92.55% |
2015/10/16 | 日証協 | 574,757株 | -0.85% | 0株 | -100% | 672,874株 | +0.23% | 57,699株 | +242.49% |
2015/10/09 | 日証協 | 579,668株 | +19.38% | 114,900株 | +39.36% | 671,344株 | +0.15% | 16,847株 | -66.71% |
2015/10/02 | 日証協 | 485,557株 | -2.67% | 82,448株 | +89.61% | 670,328株 | -28.53% | 50,605株 | -53.23% |
2015/09/25 | 日証協 | 498,885株 | +1.46% | 43,484株 | -89.14% | 937,917株 | +13.22% | 108,200株 | -86.56% |
2015/09/18 | 日証協 | 491,685株 | +36.04% | 400,511株 | +504.86% | 828,417株 | +53.12% | 805,353株 | +495.19% |
2015/09/11 | 日証協 | 361,440株 | +0.92% | 66,215株 | +18.75% | 541,017株 | -14.26% | 135,311株 | +52.81% |
2015/09/04 | 日証協 | 358,131株 | +4.61% | 55,759株 | +216.81% | 630,981株 | -3.86% | 88,548株 | +433.42% |
2015/08/28 | 日証協 | 342,352株 | -3.75% | 17,600株 | -78.41% | 656,281株 | -5.87% | 16,600株 | -22.79% |
2015/08/21 | 日証協 | 355,694株 | -20.19% | 81,529株 | +7311.73% | 697,192株 | -8.96% | 21,500株 | -90.63% |
2015/08/14 | 日証協 | 445,694株 | +23.38% | 1,100株 | -60.71% | 765,792株 | +30.17% | 229,499株 | +368.37% |
2015/08/07 | 日証協 | 361,236株 | -1.47% | 2,800株 | -91.05% | 588,295株 | -5.04% | 48,999株 | +468.83% |
2015/07/31 | 日証協 | 366,636株 | -3.5% | 31,300株 | -57.93% | 619,495株 | -6.14% | 8,614株 | -91.46% |
2015/07/24 | 日証協 | 379,936株 | -14.63% | 74,400株 | -52.03% | 659,995株 | -6.04% | 100,899株 | -9.59% |
2015/07/17 | 日証協 | 445,036株 | +2.32% | 155,104株 | +78.49% | 702,395株 | +6.23% | 111,599株 | -15.84% |
2015/07/10 | 日証協 | 434,955株 | +14.51% | 86,900株 | +769% | 661,195株 | +7.15% | 132,600株 | +99.4% |
※株式分割は考慮していませんのでご注意ください。
Page Top